Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Melanoma, Mesothelioma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms

NCT06092268 2023-10-23

A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

270 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

Phase 1 Unknown

30 enrolled

BreastGynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05263180 2023-10-18

A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

Phase 1 Unknown

30 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06082557 2023-10-13

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

Phase 1/2 Unknown

62 enrolled

Other solid neoplasm

Malignant Solid Tumors

NCT06082570 2023-10-13

A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients

Phase 1/2 Unknown

62 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05267899 2023-09-26

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

Phase 1 Unknown

24 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06047431 2023-09-21

A Study of QL1706H in Patients With Advanced Solid Tumors

Phase 1 Unknown

150 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT06008366 2023-09-13

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

Phase 1/2 Unknown

281 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06008379 2023-09-13

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

164 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06006793 2023-09-01

A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

Phase 1 Unknown

50 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06022276 2023-09-01

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Phase NA Unknown

46 enrolled

Other solid neoplasm

Solid Tumor

NCT06022289 2023-09-01

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors

Phase 2 Unknown

20 enrolled

Other solid neoplasm

Solid Tumor

Clinical Trials

Patriot

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

AMT-562 in Patients With Selected Advanced Solid Tumors

FAPI

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

PITHAC

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery

A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors

A Study of ICP-033 in Patients With Advanced Solid Tumors

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors

A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

KD6001 in Combination With Anti-PD-1 Antibody±Bevacizumab in Patients With Advanced HCC and Other Solid Tumors

Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma

Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors

Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies

DIDO

Study of ON 123300 in Patients With Advanced Cancer

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

A Study of GQ1005 in Subjects With HER2-Expressing Advanced Solid Tumors

Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

LuPARP

FIH

Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors

A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors

Topotecan Episcleral Plaque for Treatment of Retinoblastoma

UPLIFT

A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors

AMT-151 in Patients With Selected Advanced Solid Tumours

A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients

A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors

A Study of QL1706H in Patients With Advanced Solid Tumors

A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors

A Study of 7MW3711 in Subjects With Advanced Solid Tumors

A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors